Abstract
Ventricular septal defects (VSDs) are the most common congenital cardiac malformation at birth, with an incidence reported in literature between 15 and 40 % of total congenital heart diseases. They are usually an isolated finding; however, they can be also associated to complex congenital heart diseases [1, 2]. VSDs may be also a mechanical complication of myocardial infarction, with an incidence reported in literature of 0.26 % [3].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31:2915–57.
Ginghina C, et al. Mic tratat de cardiologie. Romania: Editura Academiei Romane; 2010. p. 563–5.
Jorge C, et al. Hybrid closure of postinfarction ventricular septal rupture enlargement after transcathether closure with Amplatzer occluder. Eur Heart J. 2012;1(1):57–9.
Haponiuk I, et al. Hybrid cardiovascular procedures in the treatment of selected congenital heart disease in children: a single-centre experience. Kardiol Pol. 2014;72(4):324–30.
Chojnicki M, et al. Intraoperative imaging of hybrid procedure for muscular ventricular septal defects closure with Amplatzer Duct Occluder II. Kardiol Pol. 2011;69(12):1280–1.
Mroczek T, et al. Hybrid, perventricular closure of muscular ventricular septal defects. Kardiol Pol. 2012;70(12):1280–2.
Haponiuk I, et al. Hybrid approach for closure of muscular ventricular septal defects. Med Sci Monit. 2013;19:618–24.
Rao K, et al. Epicardial deployment of right ventricular disk during perventricular device closure in a child with apical muscular ventricular septal defect. Ann Pediatr Cardiol. 2013;6(2):176–8.
Kim SJ, et al. The hybrid perventricular closure of apical muscular ventricular septal defect with Amplatzer duct occluder. Korean J Pediatr. 2013;56(4):176–81.
Haponiuk I, et al. Inflammatory marker levels after hybrid treatment of selected congenital heart disease in children. Kardiol Pol. 2014;72(9):798–805.
Koneti NR. Hybrid muscular ventricular septal defect closure: Surgeon or physician!! Indian Heart J. 2012;64:568–9.
Haponiuk I, et al. Alternative hybrid and staged interventional treatment of congenital heart defects in critically ill children with complex and non-cardiac problems. Videosurgery Miniinv. 2015;10(2):244–56.
Amin Z, et al. Perventricular closure of ventricular septal defects without cardiopulmonary bypass. Ann Thorac Surg. 1999;68:149–54.
Zhang GC, et al. Minimally invasive perventricular device closure of ventricular septal defect in infants under transthoracic echocardiograhic guidance: feasibility and comparison with transesophageal echocardiography. Cardiovasc Ultrasound. 2013;11:8.
Bacha E, et al. Multicenter experience with perventricular device closure of muscular ventricular septal defects. Pediatr Cardiol. 2005;26:315–22.
Michel-Behnke I, et al. Device closure of VSD by hybrid procedures. Catheter Cardiovasc Interv. 2011;77:242–51.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Butera, G., Lovin, N., Chessa, M. (2016). Hybrid Muscular Ventricular Septal Defect Closure: Literature and Results. In: Butera, G., Cheatham, J., Pedra, C., Schranz, D., Tulzer, G. (eds) Fetal and Hybrid Procedures in Congenital Heart Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-40088-4_40
Download citation
DOI: https://doi.org/10.1007/978-3-319-40088-4_40
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40086-0
Online ISBN: 978-3-319-40088-4
eBook Packages: MedicineMedicine (R0)